Search

everythinglearnresearchcommunity

for

Search:↓

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Thyroid and gonadal hormones control seasonal hair growth and molting in male European badgers.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Lowering certain hormone levels improves treatment for hair loss in young men.

Stress hormone corticosterone suppresses hair growth by affecting stem cell activity and Gas6 protein expression.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.